argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
argenx announced it will report its first quarter 2026 financial results and provide a business update via a conference call and webcast on May 7, 2026. The company is a global immunology firm focused on treating severe autoimmune diseases with novel antibody-based therapies.